The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
rigel pharmaceuticals | 127 |
pfizer | 7 |
celltech r & d | 4 |
ucb pharma | 4 |
rajdzhel farmas'jutikalz | 3 |
rigel pharmacauticals | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
2,4-pyrimidinediamine compounds and their uses | 88 | 2002 |
compositions and methods for inhibition of the jak pathway | 64 | 2009 |
wet granulation using a water sequestering agent | 44 | 2007 |
methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoun… 🛈 | 42 | 2002 |
prodrugs of 2,4-pyrimidinediamine compounds and their uses | 40 | 2005 |
carboxamide compounds for the treatment of metabolic disorders | 39 | 2008 |
ampk-activating heterocyclic compounds and methods for using the same | 37 | 2010 |
pyrimidine-2-amine compounds and their use as inhibitors of jak kinases | 32 | 2008 |
carboxamide, sulfonamide and amine compounds for metabolic disorders | 31 | 2007 |
compositions and methods for inhibition of the jak pathway | 31 | 2010 |